Our Technologies

Streamlining RNA-LNP & nanoparticle formulation from screening to manufacturing

How a nanoparticle is mixed shapes what it becomes. Size, encapsulation, internal structure and, through them, biological performance all depend on how the organic and aqueous phases meet. That is why we build on two distinct mixing technologies: microfluidics, for precise control at R&D volumes, and NanoPulse, our patented technology designed to keep the same mixing from µL screening to continuous production.

RNA-LNP formulation services
Microfluidic chip

Microfluidic mixing

Fine control and reproducibility at R&D volumes.
Micromixers leverage on chaotic laminar mixing to blend the two phases together within milliseconds, under flow conditions you set and repeat run after run.
Thanks to its ability to control very small volumes, it is the ultimate technology for RNA-LNP research & development, and is the technology behind TAMARA.

NanoPulse Working Principle based on high frequency injection

NanoPulse technology

One mixing mechanism. Any scale. Identical RNA-LNPs.
Our patented high-frequency alternating injection technology generates the same mixing event pulse after pulse, from µL-scale formulation to continuous manufacturing.
Scale-up is ensured by repeating identical mixing events rather than modifying process conditions, enabling consistent RNA-LNP characteristics across scales.